McDonald's stock was cut from buy to sell over a potential double-digit loss in sales due to weight-loss drugs.

Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...

STARING at yet another pregnancy test, Erica Coronado was thrilled but terrified. The 36-year-old had given up hope of a baby ...

Don’t be persuaded by the abundance of propaganda you see in ads, newspapers, magazines, TV, and the Internet. There is no ...

Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

Hedge fund aims to influence CEO appointment as drugmaker battles share price slump and competition from Eli Lilly.

These companies own 97% of the weight loss drug market -- which could grow tenfold over the next decade -- and are developing ...

--Activist hedge fund Parvus Asset Management is building a stake in Ozempic-maker Novo Nordisk as the drugmaker hunts for a new chief executive following a share-price slump, according to the ...

Moelis threw himself into action, developing a reputation as one of the best connected bankers on Wall Street. In 2014, Moelis & Company went public and it now has a market capitalisation of more than ...

Omada Health Inc. rang the opening bell on the New York Stock Exchange on June 6, marking its first day as a public company, ...